| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.051 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |